However, these cells were not enriched in the putative mammary cancer stem cell surface phenotype, CD44+/CD24− (Al-Hajj et al, 2003) (Supplementary Figure 1), suggesting that we have not selected for cancer stem cells in these studies and that the epigenetic changes that occurred in the sublines were a result of adaptation as opposed to selection. The gene discussed is CD44; the disease is breast cancer.